BIOMAT Database Logo BIOMAT Database Logo

Use of antagonist peptides to inhibit in vitro T cell responses to Par j1, the major allergen of Parietaria judaica pollen. 1999

R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
Dipartimento di Internistica Clinica e Sperimentale II Universita' di Napoli, Italy.

Antigenic peptides with substituted side chains inhibit immune responses to a number of recall Ags from infectious agents in vitro. Here we show that the same strategy can be applied to peptides derived from a pollen protein, the major allergen of Parietaria judaica(Par j1), a plant responsible for most allergenic sensitization in the southern Mediterranean area. Three T cell lines responding to Par j1 protein were used to identify a stimulatory peptide. Two different monosubstituted altered peptide ligands (APL) were identified that bound to the HLA-DR of the responders, did not stimulate the T cell lines on their own, and decreased the response to subsaturating amounts of the unmodified stimulatory peptide. Most important, these APL were able to inhibit the response of these cell lines to intact Par j1 protein. A third monosubstituted peptide bound to the HLA-DR but did not show inhibitory activity. The two APL had a lower affinity than the unsubstituted peptide for the HLA-DR. The last two observations make MHC blockade an unlikely explanation for the observed effect. These results indicate the action of a specific peptide-mediated antagonism that may be useful in controlling the T cell component of an allergic response.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010940 Plant Proteins Proteins found in plants (flowers, herbs, shrubs, trees, etc.). The concept does not include proteins found in vegetables for which PLANT PROTEINS, DIETARY is available. Plant Protein,Protein, Plant,Proteins, Plant
D011058 Pollen The fertilizing element of plants that contains the male GAMETOPHYTES. Male Gametes, Plant,Male Gametophytes,Microspores, Plant,Plant Microspores,Pollen Grains,Gamete, Plant Male,Gametes, Plant Male,Gametophyte, Male,Gametophytes, Male,Grain, Pollen,Grains, Pollen,Male Gamete, Plant,Male Gametophyte,Microspore, Plant,Plant Male Gamete,Plant Male Gametes,Plant Microspore,Pollen Grain
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens

Related Publications

R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
Purification of Par j I, the major allergen of Parietaria judaica pollen.
January 1988, Molecular immunology,
R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
Assignment of disulphide bridges in Par j 2.0101, a major allergen of Parietaria judaica pollen.
August 2003, Biological chemistry,
R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
cDNA cloning, expression and primary structure of Par jI, a major allergen of Parietaria judaica pollen.
March 1994, FEBS letters,
R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
Purification of Parj I, a major allergen from Parietaria, judaica pollen.
January 1989, International archives of allergy and applied immunology,
R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
Hypoallergenic variants of the Parietaria judaica major allergen Par j 1: in vitro and in vivo evaluation.
January 2003, Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) zu Frankfurt a.M,
R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
Lipid nanoparticles as delivery vehicles for the Parietaria judaica major allergen Par j 2.
January 2011, International journal of nanomedicine,
R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
cDNA cloning, sequence analysis and allergological characterization of Par j 2.0101, a new major allergen of the Parietaria judaica pollen.
December 1996, FEBS letters,
R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
HPLC purification of the main allergen of Parietaria judaica pollen.
February 1990, Molecular immunology,
R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
T cell responses to a Parietaria judaica pollen extract: comparison between Parietaria-sensitive patients, other atopics and healthy controls.
July 1989, Allergy,
R De Palma, and S Wu, and F Sallusto, and G Di Felice, and P Martucci, and D Geraci, and P Colombo, and C Troise, and G Sacerdoti, and A Nocera, and J Gorski
Basic isoforms of Par o 1, the major allergen of Parietaria officinalis pollen.
November 1995, Allergy,
Copied contents to your clipboard!